We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

62 hedge funds and large institutions have $24.4M invested in Fortress Biotech in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

7% more funds holding

Funds holding: 58 → 62 (+4)

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

0.01% less ownership

Funds ownership: 0.81% → 0.79% (-0.01%)

10% less capital invested

Capital invested by funds: $27M → $24.4M (-$2.61M)

Holders
62
Holders Change
+4
Holders Change %
+6.9%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
16
Closed
7
Calls
$18K
Puts
–
Net Calls
+$18K
Net Calls Change
-$114K

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$217K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$139K
3
HAG
HighPoint Advisor Group
Illinois
+$131K
4
ARTA
A.R.T. Advisors
New York
+$102K
5
Northern Trust
Northern Trust
Illinois
+$81.9K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$369K
2
Wells Fargo
Wells Fargo
California
-$285K
3
Renaissance Technologies
Renaissance Technologies
New York
-$256K
4
Citadel Advisors
Citadel Advisors
Florida
-$101K
5
CS
Credit Suisse
Switzerland
-$99K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$7.13M +$72.2K +1,225 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.9M +$139K +2,360 +3%
State Street
3
State Street
Massachusetts
$1.93M +$64.3K +1,091 +4%
Northern Trust
4
Northern Trust
Illinois
$1.63M +$81.9K +1,390 +5%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.19M +$12K +204 +1%
SO
6
STRS Ohio
Ohio
$633K +$77.7K +1,320 +14%
California Public Employees Retirement System
7
California Public Employees Retirement System
California
$499K – – –
Deutsche Bank
8
Deutsche Bank
Germany
$482K -$30.7K -522 -6%
CAM
9
ClariVest Asset Management
California
$477K – – –
SIM
10
Spark Investment Management
New York
$459K +$38.9K +660 +9%
Morgan Stanley
11
Morgan Stanley
New York
$451K +$12.7K +215 +3%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$428K -$707 -12 -0.2%
HAG
13
HighPoint Advisor Group
Illinois
$416K +$131K +2,217 New
TCIM
14
TIAA CREF Investment Management
New York
$377K -$11.7K -199 -3%
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$360K +$217K +3,684 +158%
TA
16
Teachers Advisors
New York
$256K +$26.7K +453 +12%
PPA
17
Parametric Portfolio Associates
Washington
$231K -$2.59K -44 -1%
Charles Schwab
18
Charles Schwab
California
$228K – – –
California State Teachers Retirement System (CalSTRS)
19
California State Teachers Retirement System (CalSTRS)
California
$209K -$7.48K -127 -4%
Millennium Management
20
Millennium Management
New York
$205K -$369K -6,267 -65%
Renaissance Technologies
21
Renaissance Technologies
New York
$199K -$256K -4,346 -57%
Wells Fargo
22
Wells Fargo
California
$188K -$285K -4,840 -61%
BRWA
23
B. Riley Wealth Advisors
Florida
$124K +$11.5K +195 +10%
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$121K -$37.2K -631 -24%
ARTA
25
A.R.T. Advisors
New York
$103K +$102K +1,727 New
1
2 3

FBIO Hedge Fund Activity: Q4 2017 in Review

62 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2017, worth a combined $24.4M — down 9.7% from $27M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new FBIO positions and 7 closed out — a net gain of 4 holders — while 17 added to existing stakes and 16 trimmed.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $217K. The largest seller was Millennium Management, cutting an estimated $369K.

  • 62 institutional investors held Fortress Biotech (FBIO) as of Q4 2017, up from 58 in Q3 2017.
  • Funds reported $24.4M of Fortress Biotech stock for Q4 2017, down 9.7% quarter-over-quarter.
  • 11 funds opened new Fortress Biotech positions in Q4 2017 and 7 closed out, a net change of +4 holders.
  • The largest Fortress Biotech buyer in Q4 2017 was Jacobs Levy Equity Management, an estimated $217K added.
  • The largest Fortress Biotech seller in Q4 2017 was Millennium Management, an estimated $369K sold.

Based on aggregated 13F filings for Q4 2017.